ANADROL-50 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Anadrol-50, and what generic alternatives are available?
Anadrol-50 is a drug marketed by Norvium Bioscience and is included in one NDA.
The generic ingredient in ANADROL-50 is oxymetholone. There is one drug master file entry for this compound. Additional details are available on the oxymetholone profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ANADROL-50?
- What are the global sales for ANADROL-50?
- What is Average Wholesale Price for ANADROL-50?
Summary for ANADROL-50
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 37 |
| Patent Applications: | 2,137 |
| Drug Prices: | Drug price information for ANADROL-50 |
| What excipients (inactive ingredients) are in ANADROL-50? | ANADROL-50 excipients list |
| DailyMed Link: | ANADROL-50 at DailyMed |
US Patents and Regulatory Information for ANADROL-50
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Norvium Bioscience | ANADROL-50 | oxymetholone | TABLET;ORAL | 016848-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
